Chaperoning heat shock proteins: Proteomic analysis and relevance for normal and dystrophin-deficient muscle

被引:40
|
作者
Brinkmeier, Heinrich [1 ]
Ohlendieck, Kay [2 ]
机构
[1] Ernst Moritz Arndt Univ Greifswald, Inst Pathophysiol, Karlsburg, Germany
[2] Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland
关键词
Chaperone; Dystrophin; Heat shock protein; Muscular dystrophy; Stress response; DUCHENNE MUSCULAR-DYSTROPHY; ALPHA-B-CRYSTALLIN; RAT SKELETAL-MUSCLE; 2-DIMENSIONAL GEL-ELECTROPHORESIS; DIFFERENTIALLY EXPRESSED PROTEINS; EXTENSOR DIGITORUM LONGUS; ACUTE CORONARY SYNDROME; MDX MOUSE MODEL; CONTRACTILE ACTIVITY; GLYCOPROTEIN COMPLEX;
D O I
10.1002/prca.201400015
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Molecular chaperones play a key role in normal muscle function and during physiological adaptations to extensive exercise and numerous forms of cellular stress. The various classes of HSPs and related chaperones are also involved in the molecular pathogenesis of a large number of neuromuscular diseases. Several MS-based proteomic studies have recently shown that the expression levels of molecular chaperones are severely altered in dystrophin-deficient muscles. Dystrophin isoform Dp427 (where Dp427 is dystrophin protein of 427 kDa) is a large membrane cytoskeletal protein and its deficiency is the primary underlying cause of Duchenne muscular dystrophy. Current efforts have focused on the establishment of a comprehensive biomarker signature of dystrophinopathy in order to improve diagnostic methods, establish reliable prognostic factors and identify novel therapeutic targets. Following an introduction into the biology of HSPs and their general role in skeletal muscle, this review outlines the proteomic profiling of molecular chaperones in dystrophinopathy. The focus is especially on the molecular fate of HSPs cardiovascular HSP (HSPB7), BC (HSPB5), HSP70 (HSPA) and HSP90 (HSPC) in dystrophin-deficient muscles and their involvement in progressive muscular dystrophy. Furthermore, the potential usage of distinct chaperones as disease markers of secondary pathobiochemical changes for the evaluation of novel treatment options is discussed.
引用
收藏
页码:875 / 895
页数:21
相关论文
共 50 条
  • [31] Carbonic anhydrase inhibitors' therapeutic effects on dystrophin-deficient mouse muscle
    Pertl, C. P.
    Segalat, L. S.
    Lochmueller, H. L.
    Thirion, C. T.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 815 - 815
  • [32] Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice
    Sandri, M
    PodhorskaOkolow, M
    Geromel, V
    Rizzi, C
    Arslan, P
    Franceschi, C
    Carraro, U
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (01): : 45 - 57
  • [33] Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle
    Thomas, GD
    Sander, M
    Lau, KS
    Huang, PL
    Stull, JT
    Victor, RG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 15090 - 15095
  • [34] Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness
    Marques, Maria Julia
    Machado, Rafael Ventura
    Minatel, Elaine
    Neto, Humberto Santo
    MUSCLE & NERVE, 2008, 37 (01) : 61 - 67
  • [35] Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells
    Meng, Jinhong
    Counsell, John
    Morgan, Jennifer E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 15
  • [36] EFFECTS OF CONTRACTILE ACTIVITY ON MUSCLE DAMAGE IN THE DYSTROPHIN-DEFICIENT MDX MOUSE
    MCARDLE, A
    EDWARDS, RHT
    JACKSON, MJ
    CLINICAL SCIENCE, 1991, 80 (04) : 367 - 371
  • [37] Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse
    Lewis, Caroline
    Ohlendieck, Kay
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (04) : 1024 - 1029
  • [38] Drastic reduction in the luminal Ca2+-binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle
    Lohan, J
    Ohlendieck, K
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2004, 1689 (03): : 252 - 258
  • [39] Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice
    Spencer, MJ
    Marino, MW
    Winckler, WM
    NEUROMUSCULAR DISORDERS, 2000, 10 (08) : 612 - 619
  • [40] Changes of skeletal muscle in young dystrophin-deficient cats: A morphological and morphometric study
    Gaschen F.
    Burgunder J.-M.
    Acta Neuropathologica, 2001, 101 (6) : 591 - 600